Purchase Order 75N91019P00261

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Ion Library Quantitation Kit on June 26, 2019, with a ceiling value of $13,879.50. Performance is scheduled to complete by July 26, 2019, with work performed in Carlsbad, California. The order covers a single unit of catalog item A26121ION at firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $8,120.00 on July 3, 2018, for one ION AMPLISEQ LIB KIT 2.0 (catalog A26120). Performance is at Bethesda, Maryland. The order carries firm fixed pricing and completed July 31, 2018. No set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for Ion Library Quantitation Kit consumables, catalog A26121, valued at $16,707.76 on May 29, 2018, with completion by July 1, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation for biological kits valued at $13,697.04, awarded July 9, 2019, with ultimate completion August 8, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price commercial item pricing with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit valued at $13,295.68 on April 2, 2019, with completion scheduled for May 1, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $10,146.00 on July 25, 2017, for laboratory supplies with ultimate completion on August 23, 2017. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>